BPG is committed to discovery and dissemination of knowledge
Editorial Open Access
Copyright ©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 21, 2026; 32(7): 116425
Published online Feb 21, 2026. doi: 10.3748/wjg.v32.i7.116425
Beyond monotherapy by acid suppression: Reshaping the management of refractory gastroesophageal reflux disease
Xin-Ye Zuo, Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
Qian-Qian Chen, Department of Gastroenterology and Hepatology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
ORCID number: Qian-Qian Chen (0009-0006-9078-5711).
Author contributions: Zuo XY contributed to the statistical analysis and writing of the original manuscript; Chen QQ contributed to the conceptualization and supervision of the manuscript. Both of the authors approved the final version to publish.
Supported by General Program of Municipal Natural Science Foundation of Beijing, No. 7232151.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Qian-Qian Chen, MD, Professor, Department of Gastroenterology and Hepatology, The First Medical Center of Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China. qian_qian_chen@163.com
Received: November 11, 2025
Revised: December 11, 2025
Accepted: December 25, 2025
Published online: February 21, 2026
Processing time: 87 Days and 8.4 Hours

Abstract

Gastroesophageal reflux disease (GERD) is highly prevalent worldwide. Although standard proton pump inhibitor (PPI) or potassium-competitive acid blocker therapy is effective in most patients, some patients develop refractory GERD (rGERD). Previous studies exploring the characteristics and risk factors for rGERD had substantial limitations. A recent multicenter cross-sectional study conducted across 18 medical centers in Shanghai directly compared GERD and rGERD, and identified prolonged disease duration and anxiety as independent high-risk factors for rGERD. Moderate-intensity physical activity for at least 90 minutes/week was found to be a protective factor. The 8-week PPI/potassium-competitive acid blocker therapy is the standard regimen for GERD, whereas adjustments are needed for rGERD, such as switching or increasing the dose of PPIs or using vonoprazan instead. Additionally, endoscopic interventions and surgeries are supplementary options for patients with rGERD. Anti-anxiety interventions, standardized exercise prescriptions, and lifestyle factors such as sleep and weight management should be explored as a “multidimensional risk-targeted intervention” for the management and treatment of rGERD. This multicenter cross-sectional study offers forward-looking findings for rGERD prevention, but has limitations: A single-region sample lacks representativeness, and its cross-sectional design requires long-term randomized controlled trial for causal evidence.

Key Words: Refractory gastroesophageal reflux disease; Anxiety; Holistic medicine; Endoscopic intervention; Multidisciplinary management

Core Tip: A recent Shanghai study identified prolonged disease duration and anxiety as key risk factors for refractory gastroesophageal reflux disease, whereas moderate physical activity is protective. Management should extend beyond standard acid suppression to include a “multidimensional” strategy incorporating anti-anxiety interventions, exercise prescriptions, and multidisciplinary collaboration. However, the study’s single-region sample and cross-sectional design necessitate future multi-regional, long-term research to validate and establish causality.



INTRODUCTION

Gastroesophageal reflux disease (GERD) is a common disorder with increasing global prevalence[1]. A recent multicenter cross-sectional study conducted across 18 medical centers in Shanghai challenged the conventional approach of treating GERD solely through acid suppression[2]. Refractory GERD (rGERD) is defined as partially responsive or non-responsive to a stable dose of a proton pump inhibitor/potassium-competitive acid blockers during a treatment period of at least 8 weeks in this study. Here, we report the first systematic comparison of GERD and rGERD in a Chinese population, identifying prolonged disease duration and anxiety[3] as independent high-risk factors. Moreover, engaging in moderate-intensity exercise for ≥ 90 minutes weekly demonstrated a protective effect. These findings provide potential criteria for early clinical identification of high-risk patients.

CLINICAL IMPLICATIONS: CONSTRUCTING A STEPPED MULTI-MODAL INTERVENTION PATHWAY FOR RGERD

Therapies for rGERD should move beyond the conventional 8-week proton pump inhibitor/potassium-competitive acid blocker regimen[4] toward individualized strategies. These include adjustments to drug selection and dosing, introduction of novel agents such as vonoprazan[5,6] and incorporation of endoscopic interventions[7] for patients unresponsive to medication. Following these treatments, patients with rGERD whose symptoms persist, particularly those presenting with extra-esophageal manifestations, should be actively considered for surgical intervention. This stepwise multi-modal treatment pathway offers a greater practical feasibility.

CONCEPTUAL EXPANSION: FROM “SINGLE-DIMENSIONAL TREATMENT” TO “PHYSIOLOGY-PSYCHOLOGY-BEHAVIOR” TRINITARIAN MANAGEMENT

Based on the potential triggers of rGERD, the concept of “multidimensional risk-targeted intervention” is proposed. This emphasizes the need to integrate lifestyle factors, such as anti-anxiety interventions, standardized exercise prescriptions, and sleep and weight management, to form a comprehensive management model encompassing physiological, psychological, and behavioral dimensions[8]. A multidisciplinary team involving otolaryngology, respiratory, and psychiatry is required to conduct a comprehensive assessment and provide integrated treatment for the patient. This model not only expands the traditional framework of GERD diagnosis and treatment but also aligns with the contemporary trend in medicine towards holistic approaches[9].

CONCLUSION

This study represents a crucial step in developing prevention and treatment strategies for rGERD, yielding findings that are academically forward-looking and clinically translatable. However, the following limitations and areas for improvement exist: First, the study exclusively enrolled patients from Shanghai, resulting in poor sample representativeness. Future research should adopt a multi-regional, multi-ethnic design (e.g., comparing rGERD prevalence between northern regions with high-salt diets and southern regions) to validate the generalizability of conclusions. Second, the cross-sectional design necessitates the establishment of a prospective, multi-center, randomized controlled trial of patients with rGERD to dynamically observe the impact of “disease duration, anxiety, and physical activity” on disease progression, thereby providing higher-level causal evidence.

Footnotes

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Gastroenterology and hepatology

Country of origin: China

Peer-review report’s classification

Scientific Quality: Grade B, Grade B

Novelty: Grade B, Grade B

Creativity or Innovation: Grade B, Grade B

Scientific Significance: Grade B, Grade B

P-Reviewer: Chen SC, PhD, China; Wang Y, MD, China S-Editor: Wu S L-Editor: A P-Editor: Zhang YL

References
1.  Fass R, Boeckxstaens GE, El-Serag H, Rosen R, Sifrim D, Vaezi MF. Gastro-oesophageal reflux disease. Nat Rev Dis Primers. 2021;7:55.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 15]  [Cited by in RCA: 121]  [Article Influence: 24.2]  [Reference Citation Analysis (0)]
2.  Zhang N, Wang Y, Fang SS, Han M, Zheng QW, Zhu YY, Zhang MY, Li JJ, Cui LX, Tian JL, Deng YH, Zhu SL, Ni HM, Zhou L, Zuo GL, Huang TS, Liao Q, Li XQ, Shang YY, Wang YJ, Tian Y, Ge LY, Han HQ, Hu WM, Jiang Y, Li YJ, Mao X, Yang LH, Yao JM, Zheng X, Wang HW, Fang SQ. Clinical characteristics and risk factors of refractory gastroesophageal reflux disease: A multicenter cross-sectional study. World J Gastroenterol. 2025;31:113060.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Reference Citation Analysis (0)]
3.  Baeisa R, Bakhshwin DM, Aljahdli E, Kattan W, Alhashmi WH, Metwalli E, Almutiry RA, Alrehaili A, Alammari AA, Alharbi M. Generalized Anxiety Disorder Associated With Gastroesophageal Reflux Disease Among the Saudi Population. Cureus. 2023;15:e50175.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
4.  ASGE Standards of Practice Committee; Desai M, Ruan W, Thosani NC, Amaris M, Scott JS, Saeed A, Abu Dayyeh B, Canto MI, Abidi W, Alipour O, Amateau SK, Cosgrove N, Elhanafi SE, Forbes N, Kohli DR, Kwon RS, Fujii-Lau LL, Machicado JD, Marya NB, Ngamruengphong S, Pawa S, Sheth SG, Thiruvengadam NR, Qumseya BJ; ASGE Standards of Practice Committee Chair. American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: summary and recommendations. Gastrointest Endosc. 2025;101:267-284.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 24]  [Reference Citation Analysis (0)]
5.  Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022;117:27-56.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 81]  [Cited by in RCA: 569]  [Article Influence: 142.3]  [Reference Citation Analysis (1)]
6.  Savarino EV, Barberio B, Scarpignato C, Savarino V, Barbara G, Bertin L, Bonazzi E, de Bortoli N, Sario AD, Esposito G, Frazzoni M, Galloro G, Gatta L, Ghisa M, Londoni C, Marabotto E, Meggio A, Pisani A, Ribolsi M, Usai Satta P, Stanghellini V, Tosetti C, Visaggi P, Zingone F, Pesce M, Sarnelli G. Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG). Dig Liver Dis. 2025;57:1550-1577.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 4]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
7.  Lee AY, Kim SH, Cho JY. Comparative evaluation of endoscopic anti-reflux mucosectomy and stretta radiofrequency ablation in the management of gastroesophageal reflux disease: insights from a retrospective multicenter cohort study. Surg Endosc. 2024;38:4278-4286.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 3]  [Reference Citation Analysis (0)]
8.  Chhabra P, Ingole N. Gastroesophageal Reflux Disease (GERD): Highlighting Diagnosis, Treatment, and Lifestyle Changes. Cureus. 2022;14:e28563.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 13]  [Reference Citation Analysis (0)]
9.  Fan D; China Institute for Development Strategy of Holistic Integrative Medicine. Holistic Integrative Medicine Declaration. Front Med. 2024;18:938-940.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]